Prenetics Global Limited
PRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 40.8% | 65.2% | 5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.3% | 40.6% | 27.5% | 28.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -168.4% | -220.3% | -1,656.3% | -1,668.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -151.2% | -288.5% | -1,446.8% | -1,388.4% |
| EPS Diluted | -3.64 | -5.58 | -37.57 | -47.04 |
| % Growth | 34.8% | 85.1% | 20.1% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |